Show simple item record

dc.contributor.authorHall, WA
dc.contributor.authorPaulson, ES
dc.contributor.authorvan der Heide, UA
dc.contributor.authorFuller, CD
dc.contributor.authorRaaymakers, BW
dc.contributor.authorLagendijk, JJW
dc.contributor.authorLi, XA
dc.contributor.authorJaffray, DA
dc.contributor.authorDawson, LA
dc.contributor.authorErickson, B
dc.contributor.authorVerheij, M
dc.contributor.authorHarrington, KJ
dc.contributor.authorSahgal, A
dc.contributor.authorLee, P
dc.contributor.authorParikh, PJ
dc.contributor.authorBassetti, MF
dc.contributor.authorRobinson, CG
dc.contributor.authorMinsky, BD
dc.contributor.authorChoudhury, A
dc.contributor.authorTersteeg, RJHA
dc.contributor.authorSchultz, CJ
dc.contributor.authorMR Linac Atlantic Consortium and the ViewRay C2T2 Research Consortium,
dc.date.accessioned2021-03-24T11:31:30Z
dc.date.available2021-03-24T11:31:30Z
dc.date.issued2019-11-01
dc.identifier.citationEuropean journal of cancer (Oxford, England : 1990), 2019, 122 pp. 42 - 52
dc.identifier.issn0959-8049
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/4446
dc.identifier.eissn1879-0852
dc.identifier.doi10.1016/j.ejca.2019.07.021
dc.description.abstractRadiation therapy (RT) is an essential component of effective cancer care and is used across nearly all cancer types. The delivery of RT is becoming more precise through rapid advances in both computing and imaging. The direct integration of magnetic resonance imaging (MRI) with linear accelerators represents an exciting development with the potential to dramatically impact cancer research and treatment. These impacts extend beyond improved imaging and dose deposition. Real-time MRI-guided RT is actively transforming the work flows and capabilities of virtually every aspect of RT. It has the opportunity to change entirely the delivery methods and response assessments of numerous malignancies. This review intends to approach the topic of MRI-based RT guidance from a vendor neutral and international perspective. It also aims to provide an introduction to this topic targeted towards oncologists without a speciality focus in RT. Speciality implications, areas for physician education and research opportunities are identified as they are associated with MRI-guided RT. The uniquely disruptive implications of MRI-guided RT are discussed and placed in context. We further aim to describe and outline important future changes to the speciality of radiation oncology that will occur with MRI-guided RT. The impacts on RT caused by MRI guidance include target identification, RT planning, quality assurance, treatment delivery, training, clinical workflow, tumour response assessment and treatment scheduling. In addition, entirely novel research areas that may be enabled by MRI guidance are identified for future investigation.
dc.formatPrint-Electronic
dc.format.extent42 - 52
dc.languageeng
dc.language.isoeng
dc.publisherELSEVIER SCI LTD
dc.rights.urihttps://www.rioxx.net/licenses/all-rights-reserved
dc.subjectMR Linac Atlantic Consortium and the ViewRay C2T2 Research Consortium
dc.subjectHumans
dc.subjectMagnetic Resonance Imaging
dc.subjectRadiation Oncology
dc.subjectQuality Assurance, Health Care
dc.subjectRadiotherapy, Image-Guided
dc.titleThe transformation of radiation oncology using real-time magnetic resonance guidance: A review.
dc.typeJournal Article
dcterms.dateAccepted2019-07-16
rioxxterms.versionAM
rioxxterms.versionofrecord10.1016/j.ejca.2019.07.021
rioxxterms.licenseref.urihttps://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfEuropean journal of cancer (Oxford, England : 1990)
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Cancer Biology/Targeted Therapy
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Targeted Therapy
pubs.publication-statusPublished
pubs.volume122
pubs.embargo.termsNot known
icr.researchteamTargeted Therapy
icr.researchteamTargeted Therapy
dc.contributor.icrauthorHarrington, Kevin


Files in this item

Thumbnail
Thumbnail
Thumbnail
Thumbnail

This item appears in the following collection(s)

Show simple item record